Trending...
- Boston: Mayor Michelle Wu Announces City's Black History Month Programming
- Boston: February is Black History Month
- Boston: Mayor Wu Announces New Road Safety Ordinance to Increase Accountability of Third Party Delivery Providers
COPENHAGEN, Denmark, Jan. 15, 2025 ~ CathVision, a renowned leader in advanced electrophysiology (EP) solutions, has announced its participation in the upcoming AF Symposium in Boston this January. The company is known for its innovative technology and strong dedication to advancing EP labs globally, making it an exciting addition to the event.
The AF Symposium is a highly anticipated global event focused on managing cardiac arrhythmias. Visitors to the CathVision booth will have the opportunity to explore the latest advancements in the ECGenius System. This system is designed to provide physicians with high-quality cardiac signal data and optimized workflows, ultimately enhancing patient care.
Attendees will also have the chance to engage with CathVision representatives and discuss their latest research and development efforts. This includes upcoming trials such as unipolar signal analysis for pulsed-field ablation and automated measures for conduction system pacing.
More on Boston Chron
One of the highlights of CathVision's participation at the AF Symposium will be their presentation of new scientific research in collaboration with New York University (NYU) Langone Health. The study, led by Dr. Alexander Kushnir and Dr. Larry Chinitz, showcases the capabilities of CathVision's technology in providing deeper clinical insights, automating measurements, and displaying information in innovative ways.
According to Dr. Kushnir, "The goal of a cardiac ablation procedure is to specifically target the arrhythmia circuit. Entrainment mapping is a critical tool that is frequently underutilized due to challenges with implementing and interpreting the technique." He further explains that their work with CathVision has led to the development of cutting-edge entrainment tools designed to help physicians detect and entrain reentrant arrhythmias and identify optimal ablation targets.
The findings from this study reinforce CathVision's commitment to advancing the field of electrophysiology and improving patient outcomes. The company looks forward to further studying the power of their technology in prospective trials.
With its participation at the AF Symposium, CathVision continues to solidify its position as a leader in the EP industry and a driving force in advancing EP labs globally. Attendees can expect to be impressed by the company's latest accomplishments and groundbreaking technology.
The AF Symposium is a highly anticipated global event focused on managing cardiac arrhythmias. Visitors to the CathVision booth will have the opportunity to explore the latest advancements in the ECGenius System. This system is designed to provide physicians with high-quality cardiac signal data and optimized workflows, ultimately enhancing patient care.
Attendees will also have the chance to engage with CathVision representatives and discuss their latest research and development efforts. This includes upcoming trials such as unipolar signal analysis for pulsed-field ablation and automated measures for conduction system pacing.
More on Boston Chron
- Boston: Article 85 Hearing - BLC - February 25, 2025 at 6 p.m.
- Boston: Request for Comments HOME-ARP Allocation Plan - Amendment #2
- Earn passive income through DAY Miner cloud mining in 2025
- Vane Airport Media Inc, The Best Travel Idea of 2025
- HVAC Systems: The Unsung Heroes in the Fight Against Flu Season
One of the highlights of CathVision's participation at the AF Symposium will be their presentation of new scientific research in collaboration with New York University (NYU) Langone Health. The study, led by Dr. Alexander Kushnir and Dr. Larry Chinitz, showcases the capabilities of CathVision's technology in providing deeper clinical insights, automating measurements, and displaying information in innovative ways.
According to Dr. Kushnir, "The goal of a cardiac ablation procedure is to specifically target the arrhythmia circuit. Entrainment mapping is a critical tool that is frequently underutilized due to challenges with implementing and interpreting the technique." He further explains that their work with CathVision has led to the development of cutting-edge entrainment tools designed to help physicians detect and entrain reentrant arrhythmias and identify optimal ablation targets.
The findings from this study reinforce CathVision's commitment to advancing the field of electrophysiology and improving patient outcomes. The company looks forward to further studying the power of their technology in prospective trials.
With its participation at the AF Symposium, CathVision continues to solidify its position as a leader in the EP industry and a driving force in advancing EP labs globally. Attendees can expect to be impressed by the company's latest accomplishments and groundbreaking technology.
Filed Under: Business
0 Comments
Latest on Boston Chron
- Kelvin Emtech and Colm Engineering Unveil Strategic Joint Venture, to Boost Data Center and Building M&E Capabilities
- The Twelfth Tony Del Plato Mystery Debuts
- TiE Boston and Venture Development Center (VDC) at UMass Boston to Collaborate on the AI VC Forum
- Eagle Coins Gold & Silver Buying: Trusted Gold and Coin Buyers Near You
- From Corporate Identity Theft to Business Success
- Leading change makers and industry experts join The Possible Zone Board of Directors
- Citizens for West Virginia Election Integrity Calls for Urgent Reforms to Safeguard State Elections
- The Arc of South Shore Announces Elizabeth Sandblom as CEO
- Patton Launches SFP-based RS-232/422/485 Serial Device Server
- Local Tech Entrepreneur Partners with WonderSouq To Offer Downtown Medford Businesses a Virtual City Experience
- Boston Bridal Atelier Enhances Luxury Experience with New Bridal Shop Location
- New Website for Solo Agers Over 50
- Malcolm-Jamal Warner Returns to Columbia for an Unforgettable Evening of Poetry & Music
- Slightly Stoopid, Damian & Stephen Marley to headline Everwild Music Festival in 2025
- Parkbench13 Media Group Inc. Seeks Artists for Sync Licensing Opportunities
- Brooke Shields Announced as a Keynote Speaker at the 2025 Simmons Leadership Conference
- The Elevated Table Project Revolutionizes Cannabis-Infused Cooking & Cocktails
- Boston: Mayor Wu Announces City's Black History Month Programming
- THSYU Opens New Doors for Accredited Investors, Bridging the Gap Between Traditional Finance and the Digital Asset Frontier
- Mardi Gras Annual Party w/Revolutionary Snake Ensemble + guests Jason Palmer & Henri Smith